1.18 USD
↗ 0.04 (3.06%)AT CLOSE (11:59 AM EDT)
Milestone Pharmaceuticals Inc. Common Shares
MISTNASDAQ • USD
1.16
↘ 0.02 (1.69%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.16
↘ 0.02 (1.69%)
Market: CLOSED
Shares of Milestone Pharmaceuticals Inc. Common Shares (MIST) are trading at $1.16. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (348.8%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, MIST is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 6, 2026.
Open?$1.15
High?$1.18
Low?$1.14
Prev. Close?$1.15
Volume?594.7K
Avg. Volume?1.3M
VWAP?$1.16
Rel. Volume?0.48x
Bid / Ask
Bid?$1.15 × 5.0K
Ask?$1.17 × 7.2K
Spread?$0.02
Midpoint?$1.16
Valuation & Ratios
Market Cap?143.2M
Shares Out?124.5M
Float?113.2M
Float %?90.9%
P/E Ratio?N/A
P/B Ratio?-7.30
EPS?-$0.55
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Employees
38
Market Cap
142.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-05-09
Address
1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
MONTREAL, A8 H4M 2X6
Phone: (514) 336-0444
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?38
Piotroski F-Score?0/9Weak
Altman Z-Score?-2.94Distress
Confidence?51%Low
Short InterestVery High
Short % of Float?12.88%High
Short Interest?14.6M
Days to Cover?13.6
Free Float113.2M
Avg Daily Volume1.1M
Settlement Date2026-07-15
Financial Health
Current Ratio?9.18Strong
Quick Ratio?9.09Strong
Cash Ratio?3.41Strong
Debt/Equity?-6.95Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-7.30CHEAP▾
S&P97
P/S?80.25HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-3.2CHEAP▾
S&P97
EV/Sales?116.68HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?348.8%STRONG▾
Peers50
S&P97
ROA?-35.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-51483000
Enterprise Value?$208.2M
Fundamentals ratios updated end of day